Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.

Kennedy NA, Rhatigan E, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW.

Aliment Pharmacol Ther. 2013 Nov;38(10):1255-66. doi: 10.1111/apt.12511. Epub 2013 Oct 5. Review.

2.

Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.

Lees CW, Maan AK, Hansoti B, Satsangi J, Arnott ID.

Aliment Pharmacol Ther. 2008 Feb 1;27(3):220-7. Epub 2007 Nov 6.

3.

The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy.

Boulton-Jones JR, Pritchard K, Mahmoud AA.

Aliment Pharmacol Ther. 2000 Dec;14(12):1561-5.

4.

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.

Domènech E, Nos P, Papo M, López-San Román A, Garcia-Planella E, Gassull MA.

Scand J Gastroenterol. 2005 Jan;40(1):52-5.

PMID:
15841714
6.

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.

Hindorf U, Johansson M, Eriksson A, Kvifors E, Almer SH.

Aliment Pharmacol Ther. 2009 Mar 15;29(6):654-61. doi: 10.1111/j.1365-2036.2008.03925.x. Epub 2008 Dec 22.

7.
8.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Prefontaine E, Macdonald JK, Sutherland LR.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000545. doi: 10.1002/14651858.CD000545.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(6):CD000545.

PMID:
19821270
9.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Prefontaine E, Macdonald JK, Sutherland LR.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD000545. doi: 10.1002/14651858.CD000545.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD000545.

PMID:
20556747
10.

6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data.

Actis GC, Pellicano R, Rosina F.

Inflamm Allergy Drug Targets. 2015;14(2):133-7. Review.

PMID:
26728773
11.

Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Taylor K, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2014 Aug 1;(8):CD010233. doi: 10.1002/14651858.CD010233.pub2. Review.

PMID:
25081347
12.

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

Timmer A, Patton PH, Chande N, McDonald JW, MacDonald JK.

Cochrane Database Syst Rev. 2016 May 18;(5):CD000478. doi: 10.1002/14651858.CD000478.pub4. Review.

PMID:
27192092
13.

[Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].

Bastida Paz G, Nos Mateu P, Aguas Peris M, Beltrán Niclós B, Rodríguez Soler M, Ponce García J.

Gastroenterol Hepatol. 2007 Nov;30(9):511-6. Spanish.

PMID:
17980127
14.

[Role of thiopurine agents in ulcerative colitis].

Chaparro M, Gisbert JP.

Gastroenterol Hepatol. 2011 Dec;34 Suppl 3:30-5. doi: 10.1016/S0210-5705(11)70096-6. Epub 2014 Oct 30. Review. Spanish.

PMID:
25443224
15.

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

Timmer A, McDonald JW, Tsoulis DJ, Macdonald JK.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000478. doi: 10.1002/14651858.CD000478.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD000478.

PMID:
22972046
16.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Chande N, Townsend CM, Parker CE, MacDonald JK.

Cochrane Database Syst Rev. 2016 Oct 26;10:CD000545. Review.

PMID:
27783843
17.

Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.

Dubinsky MC.

Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. Review.

PMID:
15354273
18.

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

Chande N, Tsoulis DJ, MacDonald JK.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD000545. doi: 10.1002/14651858.CD000545.pub4. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 26;10 :CD000545.

PMID:
23633304
19.

Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.

Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.

Aliment Pharmacol Ther. 2009 Sep 15;30(6):614-20. doi: 10.1111/j.1365-2036.2009.04073.x. Epub 2009 Jun 23.

20.

Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.

Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK.

Ther Drug Monit. 2015 Dec;37(6):797-804. doi: 10.1097/FTD.0000000000000213.

PMID:
25853923

Supplemental Content

Support Center